Approved IV Drug, Gazvya, Reduces Lupus Symptoms, Clinical Trial Finds
Published on March 10, 2026 at 03:33PM by Drugs.com - Daily MedNews
TUESDAY, March 10, 2026 — An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their...
Read the original article here: https://www.drugs.com/news/approved-iv-gazvya-reduces-lupus-clinical-trial-finds-129103.html